FATE - Fate Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

FATE is currently covered by 18 analysts with an average price target of $9.3. This is a potential upside of $8.37 (900%) from yesterday's end of day stock price of $0.93.

Fate Therapeutics's activity chart (see below) currently has 211 price targets and 187 ratings on display. The stock rating distribution of FATE is 78.38% HOLD, 18.92% BUY and 2.7% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 61.72% with an average time for these price targets to be met of 122.28 days.

Highest price target for FATE is $9, Lowest price target is $3, average price target is $4.88.

Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 06-Mar-2025.

Currently out of the existing stock ratings of FATE, 29 are a HOLD (78.38%), 7 are a BUY (18.92%), 1 are a SELL (2.7%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$5

$3.99 (395.05%)

$5

4 days ago
(06-Mar-2025)

8/12 (66.67%)

$4.09 (449.45%)

143

Hold

$4

$2.99 (296.04%)

$5

4 days ago
(06-Mar-2025)

2/3 (66.67%)

$3.09 (339.56%)

49

Hold

$3

$1.99 (197.03%)

$5

4 days ago
(06-Mar-2025)

7/13 (53.85%)

$2.09 (229.67%)

54

Hold

$6

3 months 20 days ago
(18-Nov-2024)

2/3 (66.67%)

$-1.34 (-18.26%)

111

Hold

$5

$3.99 (395.05%)

$5

6 months 16 days ago
(22-Aug-2024)

1/2 (50%)

$1.23 (32.63%)

68

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FATE (Fate Therapeutics) average time for price targets to be met?

On average it took 122.28 days on average for the stock forecasts to be realized with a an average price target met ratio 61.72

Which analyst has the current highest performing score on FATE (Fate Therapeutics) with a proven track record?

YIGAL NOCHOMOVITZ

Which analyst has the most public recommendations on FATE (Fate Therapeutics)?

Yigal Nochomovitz works at CITI and has 24 price targets and 16 ratings on FATE

Which analyst is the currently most bullish on FATE (Fate Therapeutics)?

Alethia Young with highest potential upside - $95.88

Which analyst is the currently most reserved on FATE (Fate Therapeutics)?

Jim Birchenough with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?